AB Corporate Bond ETF (EYEG) Dividend History

Dividend History

Pay Date Amount Ex Dividend Date Record Date
June 05, 2025 $0.15 06/02/2025 06/02/2025
May 06, 2025 $0.15 05/01/2025 05/01/2025
April 04, 2025 $0.15 04/01/2025 04/01/2025
March 06, 2025 $0.14 03/03/2025 03/03/2025
February 06, 2025 $0.14 02/03/2025 02/03/2025
Show more

Dividends Summary

  • AB Corporate Bond ETF has issued 18 dividends over a period of about a year
  • The most recent dividend was paid 3 days ago, on June 5, 2025
  • The first recorded dividend was paid on January 4, 2024
  • The highest dividend payout was $0.47 per share
  • The average dividend over this 1 year span is $0.16 per share
  • AB Corporate Bond ETF has increased its dividend payments by 65.06% since 2024

Company News

  • This article provides a beginner's guide to investing in different types of bonds, including municipal, corporate, government, and foreign bonds. It discusses factors to consider when choosing bonds, such as risk tolerance, investment goals, and tax implications. The article also outlines several bond investment strategies for beginners.

    Benzinga
    Featured Companies: GOVT
  • Investing in penny stocks in 2021? Check these three out for next months watchlist The post Best Penny Stocks to Buy Right Now? 3 to Watch in October appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: KOS
  • Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: CASI
  • Biotech Penny Stocks Surge As Sector Reverses Course The post 4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: ENVB IBB
  • WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today announced that EyeGate’s President and Chief Executive Officer, Brian M. Strem, Ph.D., will provide a corporate update and participate in one-on-one investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference to be held September 13-15, 2021.

    GlobeNewswire Inc.
Dividend data last updated 06/08/2025 01:55:16 UTC